The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs.

The signers acknowledged that leaders of their professions had previously condemned a street protest against lockdown ...

In an editorial in medical journal JAMA, FDA Commissioner Marty Makary and the new director of the Center for Biologics Evaluation and Research (CBER), Vinay Prasad, also said they aim to work ...

After the Trump administration launched a broadside attack against the way the federal government has funded major research ...

What the new FDA commissioner says about possible restrictions on abortion medication Many conservatives want the FDA to impose tighter restrictions on mifepristone and misoprostol, which can be ...